1. Home
  2. SCHW vs AZN Comparison

SCHW vs AZN Comparison

Compare SCHW & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles Schwab Corporation (The)

SCHW

Charles Schwab Corporation (The)

N/A

Current Price

$98.40

Market Cap

167.1B

Sector

Finance

ML Signal

N/A

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

N/A

Current Price

$203.87

Market Cap

316.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCHW
AZN
Founded
1971
1992
Country
United States
United Kingdom
Employees
32700
96100
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.1B
316.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCHW
AZN
Price
$98.40
$203.87
Analyst Decision
Buy
Strong Buy
Analyst Count
18
1
Target Price
$112.56
N/A
AVG Volume (30 Days)
7.9M
1.8M
Earning Date
04-16-2026
04-29-2026
Dividend Yield
1.30%
1.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.97
$10.35
Revenue Next Year
$8.93
$6.43
P/E Ratio
$20.51
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$73.76
$66.16
52 Week High
$107.50
$212.71

Technical Indicators

Market Signals
Indicator
SCHW
AZN
Relative Strength Index (RSI) 64.61 61.97
Support Level $99.51 $182.39
Resistance Level $106.02 $211.32
Average True Range (ATR) 2.45 3.36
MACD 0.77 0.22
Stochastic Oscillator 99.27 83.60

Price Performance

Historical Comparison
SCHW
AZN

About SCHW Charles Schwab Corporation (The)

Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.9 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of 2025. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: